Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...
From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...
New gene-editing tools – most notably the Nobel Prize-winning CRISPR-Cas9 – allow targeted tweaks to a crop’s genome, ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an effective cure for beta-thalassemia and sickle cell disease in children younger ...
Kennesaw State University senior biology major Ari Schwartz has been recognized with the President’s Award of Distinction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback